Kristen Fortney, PhD, is CEO and Co-Founder of BioAge, a fellow biotech aiming to extend healthy lifespan by targeting molecular causes of aging. Kristen received her PhD in Medical Biophysics from the University of Toronto, followed by postdoctoral training at Stanford University. She has over 10 years of experience developing novel bioinformatics approaches for data-driven investigation into the mechanisms of aging and age-related disease, with 18 published papers spanning computational drug discovery, biomarkers of aging, and the genetics of exceptional human longevity.